RecruitingNCT05411445

Study of Role of Blood Microvescicles and Exosomes in Patients With Graft Occlusion After Aortocoronary Bypass Surgery


Sponsor

Maria Cecilia Hospital

Enrollment

300 participants

Start Date

Jun 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Coronary artery bypass graft (CABG) surgery is still the standard treatment of coronary revascularization for patients with severe coronary artery disease (CAD). Graft patency, together with completeness of revascularization, is a major determinant of long-term outcome following CABG. The surgical procedure elicits a persistent systemic inflammatory response associated with the activation of the hemostatic system leading to perturbation of endothelial and vascular function and activation of platelets and leukocytes. All of these events are the main players responsible for the early and late graft failure in a significant percentage of patients.


Eligibility

Min Age: 40 YearsMax Age: 80 Years

Inclusion Criteria5

  • between the ages of 40 and 80
  • Ejection fraction> 30%
  • coronary artery bypass surgery
  • informed consent
  • Willingness to carry out the follow-up visits and the assessments required by the protocol

Exclusion Criteria4

  • emergency intervention
  • changes in liver or kidney function
  • changes in coagulation factors
  • associated interventions (valve replacement, carotid endarterectomy)

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

MCH

Cotignola, Ravenna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05411445